Gedeon Richter

Gedeon Richter Becomes Strategic Investor of Formycon

Hungary-headquartered specialty pharmaceutical company Gedeon Richter becomes a strategic investor of German biosimilars company Formycon via cash capital increase of 9.08% of Formycon’s share capital, which corresponds to €82.84 million.

Potential In Eastern Europe

Russia’s and Eastern Europe’s Booming Pharma Industry

Global Pharma to Pump Cash Into Russia